Study: Myo-inositol may lower gestational diabetes risk

01/31/2013 | Reuters

Taking myo-inositol supplements may reduce the likelihood of gestational diabetes among pregnant women at risk for the condition, according to a small study in Diabetes Care. Data on 220 pregnant women with a family history of type 2 diabetes showed 6% of those who took myo-inositol supplements in addition to folic acid developed gestational diabetes, compared with 15% of those only given folic acid.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ